Biochemical marker research in hemophilic arthropathy: A systematic review.

[1]  F. Staes,et al.  Paediatric patients with blood‐induced ankle joint arthritis demonstrate physiological foot joint mechanics and energetics during walking , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[2]  L. V. van Vulpen,et al.  Synovitis and synovectomy in haemophilia , 2020, Haemophilia : the official journal of the World Federation of Hemophilia.

[3]  K. Wang,et al.  Diagnostic Values of Inflammatory and Angiogenic Factors for Acute Joint Bleeding in Patients With Severe Hemophilia A , 2020, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[4]  W. Mali,et al.  MRI predicts 5-year joint bleeding and development of arthropathy on radiographs in hemophilia. , 2020, Blood advances.

[5]  I. Szilagyi,et al.  Osteoarthritis year in review 2019: biomarkers (biochemical markers). , 2019, Osteoarthritis and cartilage.

[6]  E. Rodríguez‐Merchán.  Serological biomarkers in hemophilic arthropathy: Can they be used to monitor bleeding and ongoing progression of blood-induced joint disease in patients with hemophilia? , 2019, Blood reviews.

[7]  M. Karsdal,et al.  Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII‐deficient mice , 2019, Journal of thrombosis and haemostasis : JTH.

[8]  M. Amling,et al.  Bone Mineral Density and Bone Microstructure in Patients with Haemophilia in Northern Germany: Preliminary Findings of a Single Centre Study , 2019, 49. Hamburger Hämophilie Symposion.

[9]  W. Mali,et al.  Diagnostic accuracy of point‐of‐care ultrasound for evaluation of early blood‐induced joint changes: Comparison with MRI , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[10]  C. Blobel,et al.  Blood-induced bone loss in murine hemophilic arthropathy is prevented by blocking the iRhom2/ADAM17/TNF-α pathway. , 2018, Blood.

[11]  C. Négrier,et al.  Evaluation of early musculoskeletal disease in patients with haemophilia: results from an expert consensus , 2018, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[12]  F. Lafeber,et al.  The combination of urinary CTX‐II and serum CS‐846: Promising biochemical markers to predict radiographic progression of haemophilic arthropathy—An exploratory study , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[13]  E. Terpos,et al.  The role of sclerostin/dickkopf‐1 and receptor activator of nuclear factor kB ligand/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross‐sectional study , 2018, Haemophilia : the official journal of the World Federation of Hemophilia.

[14]  M. Karsdal,et al.  The endothelial specific isoform of type XVIII collagen correlates to annual bleeding rate in haemophilia patients , 2018, PloS one.

[15]  M. Karsdal,et al.  Increased basement membrane turnover and strongly attenuated interstitial matrix turnover is a key pathological feature of haemophilia , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

[16]  Y. Zhao,et al.  Serological biomarkers detect active joint destruction and inflammation in patients with haemophilic arthropathy , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

[17]  F. Lafeber,et al.  Differential effects of bleeds on the development of arthropathy – basic and applied issues , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

[18]  M. Pisters,et al.  Comparing findings of routine Haemophilia Joint Health Score and Haemophlia Early Arthropathy Detection with UltraSound assessments in adults with haemophilia , 2017, Haemophilia : the official journal of the World Federation of Hemophilia.

[19]  F. Lafeber,et al.  Pathophysiology of hemophilic arthropathy and potential targets for therapy , 2017, Pharmacological research.

[20]  Pei-Chin Lin,et al.  Soluble vascular cell adhesion molecular-1 is a potential biological indicator of hemophilic arthropathy , 2016, Medicine.

[21]  J. Oldenburg,et al.  Potential biomarkers of haemophilic arthropathy: correlations with compatible additive magnetic resonance imaging scores , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[22]  M. Karsdal,et al.  Altered collagen turnover in factor VIII‐deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia , 2016, Journal of thrombosis and haemostasis : JTH.

[23]  K. El-Noueam,et al.  Serum cartilage oligomeric matrix protein reflects radiological damage and functional status in hemophilic arthropathy patients , 2016 .

[24]  M. Franchini,et al.  Gait analysis in children with haemophilia: first Italian experience at the Turin Haemophilia Centre , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[25]  V. Stoica,et al.  Biomarkers in Rheumatoid Arthritis, what is new? , 2016, Journal of medicine and life.

[26]  I. C. Schaaf,et al.  Value of routine ultrasound in detecting early joint changes in children with haemophilia using the ‘Haemophilia Early Arthropathy Detection with UltraSound’ protocol , 2016, Haemophilia : the official journal of the World Federation of Hemophilia.

[27]  I. Lazzareschi,et al.  High serum sclerostin levels in children with haemophilia A , 2016, British Journal of Haematology.

[28]  P. Welsing,et al.  Systemic biochemical markers of joint metabolism and inflammation in relation to radiographic parameters and pain of the knee: data from CHECK, a cohort of early-osteoarthritis subjects. , 2013, Osteoarthritis and cartilage.

[29]  L. V. van Vulpen,et al.  Biochemical markers of joint tissue damage increase shortly after a joint bleed; an explorative human and canine in vivo study. , 2015, Osteoarthritis and cartilage.

[30]  W. Drechsler,et al.  Outcome measures monitoring physical function in children with haemophilia: a systematic review , 2014, Haemophilia : the official journal of the World Federation of Hemophilia.

[31]  J. Palmblad,et al.  Angiogenesis is increased in advanced haemophilic joint disease and characterised by normal pericyte coverage , 2014, European journal of haematology.

[32]  S. Karras,et al.  The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B , 2013, Haemophilia : the official journal of the World Federation of Hemophilia.

[33]  C. Vergin,et al.  The investigation of relationship between joint findings and serum angiogenic and inflammatory factor levels in severe hemophilia A patients , 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[34]  F. Lafeber,et al.  Osteoarthritis year 2013 in review: biomarkers; reflecting before moving forward, one step at a time. , 2013, Osteoarthritis and cartilage.

[35]  R. Ljung,et al.  Intermediate-dose versus high-dose prophylaxis for severe hemophilia: comparing outcome and costs since the 1970s. , 2013, Blood.

[36]  M. Ozdemir,et al.  Evaluation of bone mineral density in Turkish children with severe haemophilia A: Ankara hospital experience , 2012, Haemophilia : the official journal of the World Federation of Hemophilia.

[37]  G. Spotts,et al.  Trends in bleeding patterns during prophylaxis for severe haemophilia: observations from a series of prospective clinical trials , 2011, Haemophilia.

[38]  R. Kaplan,et al.  Neoangiogenesis contributes to the development of hemophilic synovitis. , 2011, Blood.

[39]  M. Economou,et al.  Comparative study of dual energy X‐ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia , 2011, Haemophilia : the official journal of the World Federation of Hemophilia.

[40]  K. Amano,et al.  [Matrix metalloproteinase (MMP)-3 is not effective for evaluating hemophilic arthropathy]. , 2011, Rinsho byori. The Japanese journal of clinical pathology.

[41]  A. Doria.  State‐of‐the‐art imaging techniques for the evaluation of haemophilic arthropathy: present and future , 2010, Haemophilia : the official journal of the World Federation of Hemophilia.

[42]  A. Iorio,et al.  Bone mineral density in haemophilia patients. A meta-analysis. , 2010, Thrombosis and haemostasis.

[43]  G. Dolan,et al.  Changing patterns of bleeding in patients with severe haemophilia A , 2009, Haemophilia : the official journal of the World Federation of Hemophilia.

[44]  J. Bijlsma,et al.  The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy. , 2009, Arthritis and rheumatism.

[45]  C. Lewis,et al.  Association of HIV Infection and HIV/HCV Coinfection With C-Reactive Protein Levels: The Fat Redistribution and Metabolic Change in HIV Infection (FRAM) Study , 2008, Journal of acquired immune deficiency syndromes.

[46]  D J Hunter,et al.  Classification of osteoarthritis biomarkers: a proposed approach. , 2006, Osteoarthritis and cartilage.

[47]  D. Grobbee,et al.  Association between joint bleeds and pettersson scores in severe haemophilia , 2002 .